Bio-Rad Laboratories, Inc. (BIO)
Last updated: 2026-10-22 09:08:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Bio-Rad Laboratories, Inc. (BIO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NYSE. The stock is currently priced at $360.57, with a market capitalization of $9.48B and a P/E ratio of 43.34. Over the past 52 weeks, its price has ranged from $236.73 to $396.23. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$9.48B | |
$360.51 | |
$832.70 | |
$46.54 | |
$360.50 | |
2.00 | |
267.89K | |
43.34 | |
$396.23 | |
$236.73 | |
-- | |
-- |
Bio-Rad Laboratories, Inc. (BIO) Pre-Market Stock Price
Bio-Rad Laboratories, Inc. (BIO) is trading at $360.57 in pre-market trading as of 2026-10-22 08:16:00, up 0.02% ($0.07) from the previous close of $360.50
Pre-market trading shows how investors are pricing BIO before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Bio-Rad Laboratories, Inc. (BIO) 7-Day Stock Price Change
Over the past seven days, Bio-Rad Laboratories, Inc. (BIO) moved from $363.73 to $360.57, representing a decline of 0.87% ($3.16).
The stock traded between $347.29 and $371.07 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 239.90 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
BIO 52-Week Price Position
Position in Range: 77.6%
BIO is currently trading at $360.57, placing it 77.6% of the way from its 52-week low of $236.73 to its 52-week high of $396.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Bio-Rad Laboratories, Inc. (BIO)?
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Bio-Rad Laboratories, Inc. Information
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 7450 |
| Exchange | NYSE |
| Company Website |
How to Buy Bio-Rad Laboratories, Inc. (BIO) Stock on MEXC
Eligible investors can buy real shares of Bio-Rad Laboratories, Inc. (BIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Bio-Rad Laboratories, Inc. (BIO) stock price today?
2.Is BIO stock going up or down today?
3.What is BIO pre-market price?
4.What is BIO after-hours price?
5.Is BIO stock trading now?
6.Where does BIO sit relative to its 52-week high and low?
7.What sector is Bio-Rad Laboratories, Inc. in?
8.What is Bio-Rad Laboratories, Inc.'s market capitalization and where is it listed?
9.How is BIO valued in terms of P/E ratio and EPS?
10.Does Bio-Rad Laboratories, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BIO Stock Calculator
Estimate the value between BIO shares and USD.
BIO Shares to USD
1.00 BIO shares = 360.568 USD
Calculations are estimates based on the latest available price and are for reference only.


